KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Net Margin (2016 - 2025)

Historic Net Margin for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to 24.85%.

  • Idexx Laboratories' Net Margin rose 9800.0% to 24.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 24.65%, marking a year-over-year increase of 21200.0%. This contributed to the annual value of 22.78% for FY2024, which is 3000.0% down from last year.
  • As of Q3 2025, Idexx Laboratories' Net Margin stood at 24.85%, which was up 9800.0% from 26.5% recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Net Margin peaked at 26.5% during Q2 2025, and registered a low of 15.34% during Q2 2022.
  • Moreover, its 5-year median value for Net Margin was 23.19% (2022), whereas its average is 22.76%.
  • As far as peak fluctuations go, Idexx Laboratories' Net Margin tumbled by -91000bps in 2022, and later skyrocketed by 84300bps in 2023.
  • Quarter analysis of 5 years shows Idexx Laboratories' Net Margin stood at 20.32% in 2021, then grew by 2bps to 20.78% in 2022, then grew by 4bps to 21.58% in 2023, then increased by 5bps to 22.65% in 2024, then increased by 10bps to 24.85% in 2025.
  • Its Net Margin stands at 24.85% for Q3 2025, versus 26.5% for Q2 2025 and 24.31% for Q1 2025.